News + Filings Holdings
All
13F
13D/G
Other
|
|
Iridian Asset Management
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/03/2023 |
SC 13G
| Iridian Asset Management reports a 6.8% stake in Katapult Holdings, Inc. |
| 01/31/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/07/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/29/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/02/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/10/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/18/2022 |
SC 13G/A
| Iridian Asset Management reports a 0% stake in Travel & Lesiure Co. |
| 01/18/2022 |
SC 13G/A
| Iridian Asset Management reports a 0% stake in FinServ Acquisition Corp Class A |
| 01/18/2022 |
SC 13G/A
| Iridian Asset Management reports a 0% stake in Axsome Therapeutics, Inc. |
| 11/10/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/11/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/11/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/08/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/04/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2021 |
SC 13G
| Iridian Asset Management reports a 5.5% stake in Axsome Therapeutics, Inc. |
| 01/06/2021 |
SC 13G
| Iridian Asset Management reports a 17.1% stake in FinServ Acquisition Corp Class A |
| 11/02/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/10/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/11/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/03/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/28/2020 |
SC 13G/A
| Iridian Asset Management reports a 6.4% stake in Wyndham Destinations, Inc.. |
| 01/28/2020 |
SC 13G/A
| Iridian Asset Management reports a 0% stake in The Chemours Company |
| 01/28/2020 |
SC 13G/A
| Iridian Asset Management reports a 0% stake in Univar Inc. |
| 01/28/2020 |
SC 13G/A
| Iridian Asset Management reports a 0% stake in The Medicines Company |
| 01/28/2020 |
SC 13G/A
| Iridian Asset Management reports a 0% stake in Halozyme Therapeutics, Inc. |
| 11/06/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/04/2019 |
SC 13G/A
| Iridian Asset Management reports a 0% stake in Visteon Corporation |
| 07/31/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/06/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/07/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/06/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/06/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/06/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|